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ABSTRACT 
 The present work explores bioactive glass nanoparticles (BGNPs) and developed 
strontium-doped nanoparticles (BGNPsSr), envisioning orthopedic strategies compatible with 
vascularization. The nanoparticles were synthesized by sol-gel, achieving a diameter of 55 nm 
for BGNPs and of 75 nm for BGNPsSr, and the inclusion of strontium caused none structural 
alteration. The nanoparticles exhibited high cytocompatibility for HUVECs and SaOS-2. 
Additionally, the incorporation of strontium emphasized the tubule networking behavior of 
HUVECs. Our results demonstrate that the nanoparticles dissolution products encouraged the 
osteogenic differentiation of hASCs as it favored the expression of key genes and proteins 
associated with the osteogenic lineage. This effect was markedly enhanced for BGNPsSr, that 
could prompt stem cell osteogenic differentiation without the typical osteogenic inducers. This 
study not only supports the hypothesis that bioactive glass nanoparticles might play a significant 
role in osteogenic commitment but also highlights that the designed BGNPsSr is a valuable tool 
for stem cell “tune-up” in bone tissue engineering applications.  
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INTRODUCTION 
Traumatic injuries, infections or tumor resections can originate critical-sized bone defects that 
cannot regenerate per se. The current treatments using autografts or allografts are limited due to 
recurrent second site surgery, donor site morbidity, limited availability, immunological rejection, 
disease transmission, high costs, and limited integration with natural bone. In this regard, 
bioactive glasses find use as a standard alternative for allografts in orthopedic treatments due to 
their excellent tissue integration.1-2 Upon implantation into bone defects, they can induce a 
bone-like apatite layer on their surface, stimulate osteogenesis, angiogenesis, and promote high 
osteoinduction rates.3-4 These features are crucial for an interfacial bonding between the bone 
and the implant, leading to osteointegration.5 However, their outcome is unsatisfactory compared 
to biological grafts, and bone tissue regeneration requires materials that mimic the natural bone 
nanostructured niche.6 
 It was also found that the communications between cells and biomaterials occur on the 
nanoscale.7 At this level, several interrelated properties regulate the cell-biomaterial interactions 
such as nanotopography, surface area, energy, hydrophilicity, or chemical composition.8-9 These 
features govern the contacts with proteins, modulate cell adhesion, spreading, proliferation and, 
at last, they affect the long-term functionality of implants.10-11 Thus, in recent years, 
nanotechnology tools have been explored to develop bioactive glass nanoparticles (BGNPs).12 
Indeed, the use of nano-sized bioactive glass offers advantages over bulk bioactive glasses once 
they maximize the surface area, enhance the dissolution of the ions, amplify in vitro bioactivity, 
and improve mechanical properties of nanocomposites when used as filler material.13-14 
Composites based on polymers and BGNPs could mimic the natural bone structure, as organic 
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and inorganic phases compose the extracellular matrices of hard tissues, showing potential for 
bone tissue engineering and periodontal regeneration.15 Thus, the nanoparticulate form of 
bioactive glasses could be an ideal bioactive ‘nanocomponent’ for bone scaffolds.16-17 
 The ionic constituents of the glass network could enhance the therapeutic performance of 
bioactive glasses.18 Therefore, there is a high demand to develop new BGNPs with a tailored 
chemical composition for broader applications. In this regard, strontium (Sr) has attracted 
attention due to its therapeutic effects on orthopedics.19 Physiologically, Sr is a trace element in 
human hard tissues that can accumulate in the bone and displace calcium in the apatite phase of 
bone mineral.20 Moreover, Sr was correlated with an increase of bone compressive strength and, 
its deficiency has shown detrimental effects in hard tissues.21 Sr ions could stimulate bone 
formation and decrease bone resorption both in vitro and in vivo being, therefore, used as a 
pharmaceutical agent for treatment of osteoporosis.22 Due to its benefits, Sr has been proposed as 
a therapeutic ion to be incorporated in several bioactive glasses.18 Also, Sr-containing bioactive 
glasses stimulated osteogenic differentiation of periodontal ligament cells,23 mesenchymal 
stromal cells,24 and human bone marrow stromal cells.25 However, typical compositions of 
bioactive glasses have several components, e.g. Na, which is a network modifier that lowers the 
melting point of the glass.26 Therefore, when considering BGNPs as a reservoir for the delivery 
of therapeutic ions, more simple compositions are needed. Minimalistic compositions can be 
synthesized using the sol-gel process as it enables a control of the reaction kinetics.27 
 Herein, the compositional flexibility of the sol‑gel method was exploited to incorporate 
strontium (Sr) into ternary based BGNPs in order to improve its biological outcome, without 
increasing the amount of network modifiers. The developed quaternary strontium doped 
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bioactive glass nanoparticles (BGNPsSr) have been successfully used in nanocomposite bio-inks 
in the biofabrication of 3D bioactive structures with proven bioactivity.28 Consequently, an in-
depth knowledge of this nanoparticles became needed. Therefore, this work aimed to study the 
physicochemical changes of the strontium incorporation, estimate the viability and cellular 
functionality of relevant cell types, and evaluate the osteogenic potential of the produced 
nanoparticles unveiling the possible stimulating effects of released Sr ions on stem cells 
osteogenic differentiation. For this purpose, osteoblast-like cells (SaOS-2) and endothelial-like 
cells (HUVECs), will be employed for cytocompatibility studies as they are cell types known to 
be involved in the physiologically bone regeneration process. Hence, human adipose stem cells 
(hASCs) will be used to mimic the cellular events of the bone formation process, from the stage 
of osteoprogenitor cell proliferation to the stages of osteogenic maturation. We hypothesized that 
the BGNPsSr might be effective in the osteogenesis of cells which ultimately contributes to the 
successful regeneration of bone defects.  
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RESULTS AND DISCUSSION  
PRODUCTION AND CHARACTERIZATION OF THE NANOPARTICLES 
 By exploiting the flexibility of the sol-gel method, two types of nanoparticles were 
produced: ternary nanoparticles (BGNPs), and quaternary strontium-doped nanoparticles 
(BGNPsSr). The conventional sol-gel process (Stöber method) to produce nanoparticles started 
with the hydrolysis of Si, Ca, P and Sr precursors. Silicon was introduced through the hydrolysis 
and condensation of TEOS that occurred in an ethanolic medium in the presence of ammonium 
water. Calcium nitrate and strontium nitrate respectively supplemented calcium and strontium in 
the formulation. Diammonium hydrogen phosphate was used to add phosphate. Herein, we also 
used ammonium water to induce precipitation, combining the traditional sol-gel route with co-
precipitation methods. Figure 1A shows the production steps of the sol-gel method and reveal 
the characteristic morphology of the produced nanoparticles. Even though the particles appear 
irregularly shaped, no significant differences in the morphology between the two compositions 
were found (Figure S1). The BGNPs were composed by SiO2:CaO:P2O5 (mol%) = 55:40:5, 
while the BGNPsSr comprised SiO2:CaO:P2O5:SrO (mol%) = 55:30:5:10 (Figure 1B, Table S1 
and Figure S2). The abundance of the identified elements is in agreement with the starting 
compositions of the sol-gel mixtures used for producing the distinct nanoparticles (Table S2). 
Both nanoparticles presented a heterogeneous size that could vary in the range 40-100 nm for 
BGNPs and from 30-200 nm for BGNPsSr (Figure 1C), denoting that the Sr incorporation slight 
affects the size of the particles. A possible explanation of the larger particle side could reside in 
the larger ionic radius of Sr (0.112 nm) compared with Ca (0.099 nm) as replacing calcium with 
Sr on a molar basis lead to more open silicate networks.29-31 The nanoparticles composition was 
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also assessed by FTIR spectroscopy (Figure 1D) that showed the bending and stretching 
vibrations assigned to the silica network existing in bioactive glasses (460 and 810 and 
1030 cm−1). The hydro-affinity property of the nanoparticles was investigated by water contact 
angle and the calculated surface energy (Figure S3). Both nanoparticles demonstrated to possess 
water affinity. This phenomenon could favor the water diffusion and the hydrolytic degradation 
and the consequent ionic release. Previous studies have reported the water contact angle reduced 
to 60-65º could favor cell adhesion.32 
 
Figure 1. Production scheme and characterization of the developed nanoparticles. A) Synthesis 
of the nanoparticles by sol-gel methodology with SEM micrographs of BGNPs and BGNPsSr. 
Scale bar = 200 nm. B) Identification of chemical elements using EDS. C) Evaluation of the size 
distribution. D) FTIR (Fourier-transform infrared) spectra of BGNPs and BGNPsSr. 
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THE BIOACTIVE BEHAVIOR OF THE NANOPARTICLES  
 Bearing in mind bone tissue applications, the osteoconductive potential of the 
nanoparticles was evaluated through biomineralization studies (Figure 2A). The formation of a 
bone-like apatite layer when the material contacts with SBF is an in vitro bioactivity indicator of 
the bioglass tissue interaction in an implant scenario (Table S3).33 One day after immersion in 
SBF, the samples revealed a rough surface with mineral agglomerates that increased upon 
3 days. After 7 days, a dense apatite layer covered the nanoparticles surface showing a typical 
cauliflower morphology of hydroxyapatite that resulted from the assembling of needle-like 
crystals (Figure 2B). EDS analysis characterized the evolution of the bone-like apatite 
formation. Herein, the nanoparticles presented a gradual increase in the intensity of both Ca and 
P peaks accompanied by a steady decrease in the Si and Sr (when applicable) peaks along the 
7 days of immersion (Figure 2C and D). The growth of mineral deposits with increasing 
incubation time relates to the longer time available for apatite precipitation. Such results indicate 
the deposition and densification of the apatite layer, agreeing with the SEM images and 
consistent with previous studies.34  
 Also, the ratio of the Ca and P peaks intensity could indicate the calcification extent 
(Figure 2E). Ca/P ratios were close to the hydroxyapatite stoichiometric theoretical value (1.67) 
just after 3 days. BGNPsSr exhibits lower peaks of P and Ca than the BGNPs which denote that 
the Sr doping slightly delays the bioactive behavior of the nanoparticles. However, a faster 
apatite formation was expected, due to an increased ion dissolution rates potentiated by the 
expanded network of the Sr-doped BGNPs, that could be the result of the larger atomic size of Sr 
as compared with Ca.31 Regarding this opposite effect, it is hypothesized that the ion dissolution 
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rates are not the leading difference in apatite formation, as they are intrinsically higher due to the 
nanosize of both particles, at least at short time points. Therefore, the slight delay on apatite 
quality at day 1, might be attributed to the increasing Sr content that can slow the bioactive 
behavior of BGNPsSr, because of the inhibitory effect of Sr on the mineralization kinetics.35 
According to the classic apatite formation mechanism on bioactive glasses, the release and 
absorption of Ca from SBF onto the electronegative Si-OH groups, formed by hydrolysis of 
silicate network, attracts PO4
3- from SBF to create nucleation sites.36 Therefore, the released Sr 
into solution might interfere with apatite development by competitively binding to PO4
3- 
compared to Ca. This observation agrees with previous studies showing the formation of 
carbonated bone-like hydroxyapatite after a similar reaction time of immersion in SBF.35 
 FTIR measurements monitored the apatite formation on the surface of the nanoparticles. 
The soaked samples also showed the characteristic Si-O-Si bending and stretching vibrations at 
460, 810 and 1100 cm−1, consistent with the silica network present on bioactive glasses 
(Figure 2F). After 7 days, the samples exhibited a vibration band at 1080 cm−1 and a double 
peak at 607 and 570 cm−1, due to the stretching vibration of phosphate groups. After 7 days in 
SBF, the amorphous band (around 600 cm-1) evolves into double peak (607 and 570 cm−1), due 
to the stretching vibration of phosphate groups. The formation of the P-O dual band can be a 
bioactivity marker considered as first evidence of the appearance of crystalline carbonated 
bone-like hydroxyapatite.37 These results indicated that the produced nanoparticles induced the 
growth of hydroxyapatite on their surface. 
 The quality of apatite formation on top of the BGNPs was also followed using XRD. The 
apatite formed after 3 and 7 days resembling the typical semi-crystalline hydroxyapatite 
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diffractogram at 2θ = 25.9°, 29°, 31.8°, 32.2°, 32.9°, 34°, 39.8°, 46.7°, 49.5°, 50.5° and 53.1° 
(Figure 2G).27 
 The quantitative analysis of the ions during and after SBF immersion was performed to 
understand the dissolution kinetics of the nanoparticles (Figure 2H and Figure S5). The 
concentrations of both Ca and P decreased as they were consumed for the formation of the 
apatite bone-like on the nanoparticles surface consistent with EDS results (Table S4 and 
Table S5). The concentrations of Si ions were increased and then stagnated in the SBF solution. 
This may be due to the release of ions, loss of soluble SiO2 from the surface of the glass 
specimens to the SBF solution, condensation, and re-polymerization of the SiO2-rich layer. 
Calcium and phosphorous concentrations then dropped in the SBF solution increasing the silicon 
ion concentration after 7 days, and this may be due to the formation of an amorphous CaO-P2O5 
layer on the surface of the glass sample.38  
 Overall, our results indicated that Sr incorporation does not critically influence the 
mineralization capability of the produced nanoparticles. These results confirm not only the 
expected bioactive nature of the nanoparticles but also the osteoconductive capacity of the newly 
developed BGNPsSr. 
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Figure 2. The bioactive behavior of the produced nanoparticles. A) Schematic representation of 
the in vitro bioactivity assessment. B) Representative SEM micrographs of BGNPs and 
BGNPsSr soaked in SBF solution during 1, 3 and 7 days. Scale Bar = 5 µm. SEM micrographs 
before soaking in SBF (0days) are present in Figure S4A. C) Identification of chemical elements 
using EDS after immersion of BGNPs in SBF for 1, 3, and 7 days. D) Identification of chemical 
elements using EDS after immersion of BGNPsSr in SBF for 1, 3, and 7 days. E) Ca/P ratio 
during 1, 3 and 7 days of immersion in SBF. F) FTIR spectra of the apatite formation on the 
surface of the nanoparticles. G) XRD (X-ray diffraction) spectra obtained for BGNPs after the 
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immersion in SBF (3 and 7 days). The principal characteristic hydroxyapatite peaks are 
indicated. The spectra obtained for BGNPs before the immersion in SBF (0 days) are depicted in 
Figure S4B. H) ICP (inductively coupled plasma) analyses of the evolution of Ca, Si and Sr in 
the SBF. 
 
BIOCOMPATIBILITY ASSESSMENT OF THE BIOACTIVE GLASS NANOPARTICLES 
 In therapy scenario, biomaterials must not cause toxicity to the cells involved in bone 
regeneration. Along with new bone production, the development of vascularization is necessary 
to provide oxygen, nutrients, and growth factors essential to cell survival, integration and 
successful regeneration. This relation is referred as angiogenic-osteogenic coupling.39 Recent 
investigations demonstrated that bioactive glasses not merely enhance bone formation but could 
stimulate angiogenesis,40 and Sr ions proved advantageous.41 Therefore, a preliminary biological 
response of the produced nanoparticles was studied in agglomerated discs using two 
well-characterized cells lines, SaOS-2 and HUVECs (Figure 3A). 
 The metabolic activity was evaluated using the Alamar blue assay that relies on the 
cytoplasmic reduction potential of metabolically viable cells. A significant increase in the 
metabolism was observed up to 7 days of culture for SaOS-2, while no significant impact on 
metabolic activity was observed for HUVECs, after seeding on the agglomerated nanoparticles 
(Figure 3B). The results also showed an increase in the metabolic activity with the time in 
culture for both cells lines, regardless of the particles. These findings denote that the produced 
nanoparticles do not negatively interfere with cell metabolism. 
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 Figure 3C shows that cells were evenly distributed over the surface of the agglomerated 
nanoparticles after 1, 3 and 7 days of culture. After 1 day of culture, the nanoparticles sustained 
cell attachment, though no statistical significance was found in cell proliferation from 3 to 7 days 
(Figure 3D). Both nanoparticles formulations did not influence the spreading of SaOS-2 
(Figure 3E). However, both nanoparticles favored the spread of HUVECs in the end of the study 
period. Images were also processed with a specific software for angiogenesis analysis which can 
detect pseudo-vascular organization of endothelial cells (see figure S7). The results not only 
demonstrated that the nano-nature of the nanoparticles could enhance cell anchorage and spread, 
but also that strontium elicits a positive effect on the behavior of angiogenic cells. Interestingly, 
the BGNPsSr seemed to enhance the response of HUVECs as a rearrangement of cell 
distribution that could be associated to an eventual tubular structure formation that was observed 
after 7 days of culture (Figure 3C and Figure S7). This morphology could be an indication of 
the effect of strontium ions in the angiogenesis process (P<0.03 in the angiogenic descriptors, 
Table S6). This microvascular behavior has been similarly reported for ceramics containing 
strontium, where the ionic release played a corporative role in stimulating endothelial 
functions.42  
 Besides the positive effect of BGNPsSr on the HUVECs morphology, these results also 
showed an absence of cytotoxicity of the nanoparticles, reinforcing their appropriateness in 
tissue engineering applications. 
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Figure 3. Biocompatibility assessment. A) Schematic representation of the in vitro cell 
biocompatibility studies. B) Alamar blue assay results. C) Representative photographs of 
calcein-AM staining of SaOS-2 and HUVECs during the cell culture time (scale bar = 200 µm). 
D) Cell number of SaOS-2 and HUVECs cells seeded on BGNPs and BGNPsSr agglomerated 
samples based on an automated analysis where each particle was detected as an object 
representing a cell. E) Cell area of SaOS-2 and HUVECs cells seeded on BGNPs and BGNPsSr 
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agglomerates based on automated measurement features and analyzed after image processing 
(Figure S6). The data were normalized to the control at first time point for each cell type line. 
When applicable, (∆) depicts a positive statistical difference when compared with the control at 
each time point (nanoparticles effect), while (§) shows the statistical difference of BGNPsSr 
when compared with BGNPs (strontium effect).  
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GENE AND PROTEIN EXPRESSION TOWARDS OSTEOGENIC COMMITMENT 
 The combination of biomaterials with stem cells has demonstrated to improve bone 
healing. Stem cells could show a temporal development similar to in vivo bone formation.43 
Therefore, and considering the previous results, it becomes crucial to evaluate whether the 
nanoparticles could drive osteogenic differentiation to understand their physiological outcome. 
The cellular effect of strontium nanoscaled bioactive glasses has been reported in the literature 
(Table S7). However, studies on the effect of strontium doped bioactive glass nanoparticles in 
stem cells are still required. The osteogenic potential of the produced nanoparticles was 
examined on stem cells derived from adipose tissue (Figure 4A). These cells were chosen as the 
stem cell source due to its abundance, easy access, nonimmunogenicity, and as it represents a 
suitable cell type for clinical translation into musculoskeletal regeneration treatments.44 In this 
study, the nanoparticles were supplemented in the cell culture medium as a well-dispersed form. 
 Osteogenic differentiation is a gradual process, characterized by developmental stages, in 
which alterations in this defined sequence can induce or inhibit differentiation and so bone 
formation.45 Therefore, this temporal pattern was assessed by real-time PCR regarding the 
expression of main osteogenic differentiation genes analyzed at 7, 14, and 21 days. Runt-related 
transcription factor 2 (RUNX2) affects osteogenic differentiation in the early stages and is 
considered a key integrator in the signaling cascade as it induces other downstream osteo-related 
genes such as type I collagen, osteocalcin (OCN), and secreted phosphoprotein 1 (SPP1).46 The 
nanoparticles influenced the expression levels of RUNX2 in the initial culture periods, in which, 
a significant upregulation of RUNX2 occurred at 7 days for all the cultures media. A relationship 
with BGNPsSr only appears in the basal and osteogenic medium at 7 days, where the levels were 
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similar to the control in osteogenic medium (Figure 4B). Also, the extent of RUNX2 expression 
correlated with the expression of type I collagen, OCN, and SPP1 (P<0.03, Table S14). Collagen 
type I alpha 1 (COL1A1) is expressed in the first periods and downregulated in the succeeding 
osteoblast differentiation, being necessary for the progress of the bone cell phenotype.46 The 
results showed upregulation of COL1A1 expression at 7 days for the hASCs cultured in 
osteogenic medium and when cells were cultured with BGNPsSr despite the culture medium 
(Figure 4C). This finding denotes that the upregulation levels on the basal and osteoinductive 
media are similar to the ones ascribed to the osteogenic medium when strontium is present. 
Moreover, the BGNPsSr possess higher upregulations levels than BGNPs. Alkaline phosphatase 
(ALP) is a membrane-bound enzyme linked with osteogenic differentiation and phosphate 
metabolism.47 The results showed that both nanoparticles induced an upregulation of ALPL gene 
in the initial 7 days in all culture media (Figure 4D). These findings remain consistent with 
reports that demonstrated reduced levels of ALPL in late-stage cultures.47 This result suggested 
that the nanoparticles could enhance the ALPL activity of hASCs absent osteogenic supplements. 
Osterix (OSX) is an osteoblast transcription factor essential for osteoblast differentiation and 
bone formation (OSX knock-out mice lack bone completely).48 OSX expression was enhanced at 
7 days in osteogenic medium and remained similar in the following time points for all media. 
However, an upregulation was found for BGNPsSr in basal and osteoinductive media 
(Figure 4E). Studies have reported that only differentiated osteoblasts could express osteocalcin 
(OCN).49 Herein, the results showed that only the BGNPsSr upregulated the OCN expression at 
7 days in all culture media (Figure 4F). SPP1 expression increased at 7 days in the presence of 
both nanoparticles but was only enhanced in osteogenic medium (Figure 4G).  
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 Altogether, the upregulation of osteogenic differentiation genes were increased by both 
types of nanoparticles. However, only the BGNPsSr was capable of significantly upregulating all 
the selected genes in complete basal conditions. These findings indicate that the BGNPsSr are a 
strong inducer of stem cells through osteocommmitment, even without osteogenic 
supplementation. In this regard, the mechanism of strontium on bone formation was reported to 
involve the Ras/MAPK signaling pathway and the downstream transcription factor RUNX2.
50
 
 
Figure 4. Analysis of the gene expression for early osteogenic commitment. A) Schematic 
representation of the cell culture methodology. B) Runt-related transcription factor 2 (RUNX2) 
gene expression. The statistical analysis is represented in Table S8. C) Collagen type I 
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(COL1A1) gene expression. The statistical analysis is represented in Table S9. D) Alkaline 
phosphatase (ALPL) gene expression. The statistical analysis is represented in Table S10. 
E) Osterix (OSX) gene expression. The statistical analysis is represented in Table S11. 
F) Osteocalcin (OCN) gene expression. The statistical analysis is represented in Table S12. 
G) Secreted phosphoprotein 1 (SPP1) gene expression. The statistical analysis is represented in 
Table S13. When applicable, (∆) depicts statistical upregulation when compared with the control 
in basal media at each time point (nanoparticles effect); (§) shows the statistical difference of 
BGNPsSr when compared with BGNPs (strontium effect), while (≠) denotes a statistical 
difference when compared with the control with osteogenic media at each time point (media 
effect).  
Page 19 of 36
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
20 
 
 
 The cell metabolic activity (indirectly related to cell viability), and proliferation are 
relevant parameters in cell response. The MTS assay was used to assess cell metabolism relying 
on the mitochondrial activity of hASCs.51 Both nanoparticles supplemented in the cell culture 
medium did not affect hASCs metabolic activity (Figure 5A). The spreading of hASCs in the 
presence of nanoparticles denotes their stem cell biocompatibility. The osteogenic control had a 
significantly higher metabolic activity than both nanoparticles, which could be due to the higher 
differentiation of hASCs in the presence of both nanoparticles. Similar phenomena have been 
previously reported.52 Clusters of nanoparticles were also observed inside and on the outer 
surface of the plasma membrane of hASCs (Figure S8), engulfed by membrane protrusions 
which might indicate endocytosis (Figure 5B). 
 The osteogenic differentiation of hASCs in the presence of particles was also evaluated at 
the protein level. The expression of bone-specific proteins, osteocalcin (OCN) and osteopontin 
(OPN), were evaluated by immunofluorescence at 14 and 21 days in either basal or osteogenic 
media (Figure 5C and D). The osteoinductive medium was eliminated from this study since the 
previous results showed no relevant effect on cell behavior (Table S14). OCN is an early marker 
of osteogenic differentiation and reported as an osteoblast-specific ECM phosphoprotein known 
to be involved in cell attachment, proliferation, and in the onset of matrix deposition.53 OPN is a 
non-collagenous protein of the bone extracellular matrix (ECM) and is produced by osteoblasts 
involved in endochondral ossification.54 The osteogenic markers OCN and OPN were detected in 
all conditions, and a high protein expression up to day 14 shows bone ECM maturation (Figure 
5E and F).55 
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 Overall, the upregulation of genes and the synthesis of the selected proteins were 
increased by both nanoparticles without requiring osteogenic supplements. These findings 
further suggest that the particles and their dissolution products are likely influencing the 
commitment of hASCs toward osteoblast differentiation. It is hypothesized that ions released 
from the nanoparticles may exert an osteogenic effect by locally modifying the culture medium. 
The presence of BGNPsSr was also associated with higher stimulation of both early and late 
osteoblast markers at the gene and protein levels in comparison with BGNPs. These observations 
demonstrated the hASCs commitment towards osteoblast differentiation for all culture 
conditions. 
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Figure 5. Analysis of the protein expression for early osteogenic commitment. A) Cell viability 
of hASCs cells exposed BGNPs and BGNPsSr subtracted from the positive control (cells 
cultured in nanoparticles-free media). The statistical analysis is represented in Table S15. 
B) Scanning electron microscopic analysis of hASCs in the presence of both nanoparticles after 
14 days in culture, showing the bound cell layer covering part of the bioactive glass particle 
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surface and the cell attached to the substrate throught cytoplasmic digitations. Scale bar = 10 µm. 
C) Immunofluorescence of osteocalcin for hASCs cultured with BGNPs and BGNPs-Sr, after 14 
and 21 days in culture. Scale bar = 10 µm. D) Immunofluorescence of osteopontin for hASCs 
cultured with BGNPs and BGNPs-Sr, after 14 and 21 days in culture. Scale bar = 100 µm. 
E) Quantification of osteocalcin through image analysis. The statistical analysis is represented in 
Table S16. F) Quantification of osteopontin through image analysis. The statistical analysis is 
represented in Table S17. When applicable, (∆) depicts statistical upregulation and (∇) depicts 
statistical downregulation, when compared with the control in basal media at each time point 
(nanoparticles effect); (§) shows the statistical difference of BGNPsSr when compared with 
BGNPs (strontium effect), while (≠) denotes a statistical difference when compared with the 
control in osteogenic media at each time point (media effect).  
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CONCLUSIONS 
 In this study, we have demonstrated the biological performance of bioactive glass 
nanoparticles for osteogenic applications in bone tissue engineering. New nanoparticles doped 
with strontium ions have been successfully developed, and a comprehensive characterization for 
regenerative medicine was performed. The produced nanoparticles - BGNPs and BGNPsSr - 
presented a bioactive behavior, leading to the formation of an apatite layer on the surface when 
immersed in SBF. Moreover, HUVECs, SaOS-2 and, hASCs kept their viability levels in the 
presence of both nanoparticles in comparison with cells not exposed to the particles. The 
BGNPsSr formulation promoted the angiogenic phenotype of HUVECs. To investigate the ion 
release effect of BGNPs and BGNPsSr on osteoblast differentiation of hASCs, the gene and 
proteins expression of early and late osteoblast markers were examined. Overall, the biochemical 
data showed that the selected genes and proteins were typically expressed throughout the culture 
period indicating that both nanoparticles represent an adequate support for osteogenic 
differentiation. The results also show that the partial substitution of Ca for Sr in the nanoparticles 
is effective on favoring the expression of genes and proteins, indicating these nanoparticles could 
govern stem cells through osteocommitment, even without osteogenic supplementation. 
Therefore, the developed BGNPsSr may be used as biological agents to modulate the behavior of 
stem cells. These findings open new possibilities for BGNPsSr alone or as additives in a matrix 
(e.g., scaffolds or hydrogels) avoiding the need of culturing stem cells with typical osteogenic 
cocktails in cell culture or during the in vivo implantation. Therefore, incorporating Sr into 
BGNPs can be used to design a new generation of (i) bioactive nanocomposites or (ii) cell 
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internalizable ingredient in “scaffold-free” strategies for stem cell modulation in vascularized 
bone-engineered applications. 
METHODS 
Bioactive glass nanoparticles preparation: The preparation of the ternary form of BGNPs 
followed a described protocol comprising sequential reagent dissolutions that resulted in 
hydrolysis and polycondensation reactions (Information S1).27 A similar procedure was 
followed to obtain Sr-doped BGNPs (BGNPsSr), but in this case, the sol-gel precursor solution 
contained strontium nitrate (Sigma-Aldrich, see Table S2). 
In vitro bioactivity study: The tests were carried out for 1, 3 and 7 days at 37 °C in disc shape 
agglomerates. Discs of both BGNPs and BGNPsSr, with an approximate weight of 100 mg and 
ø 4 mm, were produced through a compact and inexpensive hand-driven press (MHP-1, 
Shimadzu; Germany), ensuring the reproducibility of the operation. The samples were immersed 
in 30 mL of simulated body fluid (SBF, Table S3) under shaking (30 rpm). After removing the 
samples from SBF, they were rinsed with distilled water, dried at 60 °C for 24 h and kept in 
desiccators. The preparation of SBF followed the protocol described by Kokubo and 
Takadama.33 
Elemental and morphological assessment: The nanoparticles were dispersed in 100% 
ethanol and fixed by mutual conductive adhesive tape. Energy dispersive spectroscopy (EDS; 
QUANTAX200 Bruker, Germany) was first performed to analyze the elemental composition of 
the nanoparticles. A scanning electron microscope (SEM; JSM-6010LV, JEOL, Japan), operated 
at 15 kV, was used to study the morphology of the nanoparticles produced. Before SEM 
acquisition, all samples were coated with a thin layer of carbon using a sputter coater (EM 
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ACE600, Leica, Germany). Images were taken after short exposure times to ensure no beam 
damage to the nanoparticles during analysis. 
Size distribution: Nanoparticles solutions were prepared at 1 mg mL-1 in ethanol, followed by 
5 min of ultrasonication, and then examined under dynamic light scattering (DLS, Malvern 
instrument 2000) at 25 ºC, setting a minimum of 10 and a maximum of 100 runs per 
measurement. The measurements were performed in triplicate. 
Fourier-Transformed Infrared (FTIR) spectroscopy analysis: The samples were dried at 
room temperature and combined with potassium bromide (KBr), producing discs. Then the 
infrared spectra were recorded using an FTIR Spectrometer (IRPrestige-21, Shimadzu; 
Germany) in the wavelength range of 4400-400 cm-1, as an average of 32 scans. 
Measurement of element concentrations in SBF: SBF solutions from the in vitro bioactivity 
study, collected at each time point, were filtered (0.22 µm), diluted (1:10) in 1% nitric acid 
(HNO3) and kept at -20 °C. The levels of calcium, phosphorous, silicon, and strontium were 
measured by inductively coupled plasma optical emission spectroscopy (ICP-OES; JY2000-2, 
Jobin Yvon, Horiba) against standard solutions. At least five samples were used per condition 
and per time point. 
X-ray diffraction (XRD) spectra of the nanoparticles: X-ray diffraction (XRD) spectra were 
collected on a Philips PW1700 Series automated powder diffractometer using Cu Ka radiation 
operated at 40 kV and 40 mA. Data were collected between 5° and 80° 2θ with a step of 0.04° 
2θ and a dwell time of 1.5 s. 
Cytotoxicity screening: A human osteosarcoma osteoblast-like cell line (SaOS-2, ATCC) and 
human umbilical vein endothelial cell line (HUVECs, Alfagene) were used as well-established 
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cell lines for preliminary cytocompatibility studies. To investigate any pH changes caused by 
BGNPs, as has been reported in the literature,30 the agglomerated discs samples of BGNPs or 
BGNPsSr (produced as described in the in vitro bioactivity study - Section 3.2) were rinsed with 
sterile PBS for 24 h. As no significant change in pH was detected over the study period (Figure 
S9), the agglomerated discs samples were used for cell culture purposes right after preparation. 
The labeling of live cells, the cytoplasm staining, and the metabolic activity protocol is detailed 
in Information S2. For quantification of cell number and cell area, all images were processed 
using algorithms developed in ImageJ (version 2.0, NIH, USA) and by using specific routines 
written by the authors. Briefly, image stacks in the green channel were used as input, and then 
thresholded, segmented, and measured by features established in the software. Six images per 
condition were used. 
Osteogenic Differentiation: Human adipose stem cells (hASCs) were cultured with bioactive 
glass nanoparticles dispersed in the medium with and without osteogenic supplements. After 
isolation and expansion (Information S3), the cells could adhere for 24 h, and the basal medium 
was replaced with osteoconductive, or osteogenic medium, either containing a dispersion of 
BGNPs or BGNPsSr at 100 µg mL-1, as higher doses showed to reduce cell viability and 
proliferation.56 For that, sterilized nanoparticles (dry heat at 180 °C for 2 h) were dispersed in an 
ultrasonic bath in α-MEM medium (with no supplementation) for 5 min, autoclaved, and then 
supplemented as the basal medium. The osteogenic medium consisted in the basal medium 
supplemented with 10 mM beta-glycerophosphate (Sigma-Aldrich), 10-8 mM dexamethasone 
(Sigma-Aldrich), and 50 mg mL-1 l-ascorbic acid 2-phosphate sesquimagnesium salt hydrate 
(Sigma-Aldrich). The osteoconductive medium was similar to osteogenic medium but without 
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dexamethasone supplementation. Cells were then incubated in a humidified environment at 
37 °C with 5% CO2 for 7, 14 and 21 days. The upper half of the culture medium was renewed 
every 3 days to ensure nanoparticles remaining at the bottom of the wells. Cells cultured in basal, 
osteogenic and osteoconductive media absent nanoparticles were experimental controls (Ctrl). 
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR): Total RNA was 
extracted using TRI Reagent (Sigma-Aldrich), following the manufacturer instructions. RNA 
quantity and purity were assessed with a NanoDrop ND-1000 Spectrophotometer (NanoDrop 
Technologies, USA). First-strand complementary DNA (cDNA) synthesis was performed using 
qScript™ cDNA synthesis Kit (Quanta Biosciences) on a Mastercycler ep realplex thermal 
cycler (Eppendorf, USA), using 1 µg of RNA.  
The quantification of the transcripts of the genes of interest was carried out by RT-PCR in a 
real-time Mastercycler® ep realplex gradient S machine (Eppendorf, USA) using PerfeCTA™ 
SYBR® Green FastMix kit (Quanta Biosciences) following the manufacturer's protocol. The 
primers were designed using the Primer 3 online software (v0.4.0, Whitehead Institute, USA) 
and synthesized by MGW Biotech (Germany). The primers sequences and annealing 
temperatures for bone-specific genes, collagen type I (COL1A1), alkaline phosphatase (ALPL), 
runt-related transcription factor 2 (RUNX2), secreted phosphoprotein 1 (SPP1), osteocalcin 
(OCN), osterix (OSX), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are depicted in 
Table S18. The relative quantification of the target genes was performed using the Livak 
method.57 For each sample, the transcripts expression data were normalized to GAPDH, used as 
the housekeeping gene, and were expressed as fold changes relative to the expression of hASCs 
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cultured in basal, osteogenic or osteoconductive medium absent bioactive glass nanoparticles 
(Ctrl). 
Cell number and metabolic activity: The quantity of double strained DNA (dsDNA) that is 
directly proportional to the cell number was determined using a fluorometric dsDNA 
quantification kit (PicoGreen, Molecular Probes, Invitrogen), according to the manufacturer's 
instructions. The effect of the nanoparticles on metabolic activity of hASCs was also investigated 
through MTS assay. The detailed protocol is described in Information S4. 
Expression of proteins associated with the osteogenic process: Immunolabelling against 
osteopontin (OPN, ab14175) and osteocalcin (OCN, ab13418) was performed after 14 and 21 
days of culture. A detailed protocol can be found in Information S5. 
Statistical analysis: Each experiment was performed with, at least, three independent 
triplicates. First, a Shapiro-Wilk test was used to ascertain the data normality. The results 
indicated that non-parametric test should be employed for all comparisons. Results are presented 
as mean ± standard deviation when applicable. Statistical analysis was performed ANOVA with 
post hoc Tukey's or Sidak's multiple comparisons tests, using GraphPad Prism v7.00 software 
(San Diego, USA). Statistical significance was set at a p-value of ≤ 0.0332 (*); ≤ 0.0021 (**); ≤ 
0.0002 (***); or ≤ 0.0001 (****). 
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